Rentschler Biopharma

Rentschler Biopharma is a leading contract development and manufacturing organization (CDMO) focused exclusively on client projects. The company offers process development and manufacturing of biopharmaceuticals as well as related consulting activities, project management and regulatory support. Rentschler Biopharma's high quality is proven by its long-standing experience and excellence as a solution partner for its clients. A high-level quality management system, a well-established operational excellence philosophy and advanced technologies ensure product quality and productivity at each development and manufacturing step. Rentschler Biopharma is a family-owned company with about 1,400 employees, headquartered in Laupheim, Germany, with operations in Milford, MA, USA.

For years, Rentschler Biopharma has supported numerous modalities on their way from concept to market, regularly contributing to biopharmaceuticals reaching market approval. In 2023 alone, we contributed to nearly 25% of all FDA-approved biologics. In 2024, the company joined the United Nations Global Compact, emphasizing Rentschler Biopharma's focus on sustainability.